Compare PLUR & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLUR | INLX |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5M | 26.4M |
| IPO Year | 2001 | 2013 |
| Metric | PLUR | INLX |
|---|---|---|
| Price | $1.84 | $5.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 37.2K | 6.7K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,336,000.00 | $11,336.00 |
| Revenue This Year | $97.38 | $16.86 |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 309.82 | N/A |
| 52 Week Low | $1.56 | $5.25 |
| 52 Week High | $5.68 | $13.98 |
| Indicator | PLUR | INLX |
|---|---|---|
| Relative Strength Index (RSI) | 35.72 | 42.48 |
| Support Level | N/A | $5.50 |
| Resistance Level | $2.50 | $7.87 |
| Average True Range (ATR) | 0.17 | 0.21 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 21.68 | 11.30 |
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.